Department of Surgery, Seoul National University College of Medicine, Seoul, Korea.
Ann Surg Oncol. 2011 May;18(5):1274-81. doi: 10.1245/s10434-010-1485-2. Epub 2011 Jan 8.
According to the AJCC/UICC TNM classification, T mesocolon invasion in AGC is classified as T2b or T3 according to the presence or the absence of serosa invasion. However, many authors have considered T mesocolon invasion in AGC as T4. This study was performed to evaluate the appropriate T stage for T mesocolon invasion in AGC.
From 1996 to 2008, 90 patients underwent curative gastrectomy with T mesocolon excision at the authors' institute under the suspicion of T mesocolon invasion based on surgical findings and without pathologic invasion to any other organ. Histopathologic findings were reviewed to determine whether tumors had invaded the T mesocolon. Survival data of AGC patients registered in the SNUH database (N = 9998, from 1986 to 2007) was used as reference data for comparative purposes.
A total of 27 patients (30%) had proven histopathological invasion of the T mesocolon, and a significant difference in survival rates was found between these 27 and the remaining 63 (P = .012). As compared with the SNUH database population, the survival rate of T mesocolon invasion patients differed from those of T2b (P < .001) and T3 (P = .043) patients, but was similar to that of T4 patients (P = .218). Furthermore, for N1 stage patients, the survival rate differed from those of T2b (P = .001) and T3 (P = .046) patients, but was similar to that of T4 patients (P = .744).
The T stage of T mesocolon invasion in AGC should be revised to AJCC/UICC stage T4, because the survival rate of T mesocolon invasion AGC is lower than that of stage T2b or T3.
根据 AJCC/UICC TNM 分期,AGC 中横结肠系膜侵犯根据浆膜侵犯的存在与否分为 T2b 或 T3。然而,许多作者将 AGC 中的横结肠系膜侵犯视为 T4。本研究旨在评估 AGC 中横结肠系膜侵犯的适当 T 分期。
1996 年至 2008 年,作者所在机构对 90 例因手术发现并怀疑横结肠系膜侵犯而行根治性胃切除术且无其他器官侵犯的患者行横结肠系膜切除术。回顾组织病理学检查结果以确定肿瘤是否侵犯了横结肠系膜。将在 SNUH 数据库(1986 年至 2007 年,N=9998)中登记的 AGC 患者的生存数据用作比较参考数据。
共有 27 例(30%)患者的横结肠系膜有明确的组织病理学侵犯,这 27 例患者与其余 63 例患者的生存率有显著差异(P=0.012)。与 SNUH 数据库人群相比,横结肠系膜侵犯患者的生存率与 T2b(P<0.001)和 T3(P=0.043)患者不同,但与 T4 患者相似(P=0.218)。此外,对于 N1 期患者,其生存率与 T2b(P=0.001)和 T3(P=0.046)患者不同,但与 T4 患者相似(P=0.744)。
AGC 中横结肠系膜侵犯的 T 分期应修订为 AJCC/UICC 分期 T4,因为横结肠系膜侵犯的 AGC 患者的生存率低于 T2b 或 T3 期患者。